End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
46.16 CNY | -0.04% | +10.27% | +2.06% |
26/04 | Hengrui Pharma Gets Nod to Trial Insulin Aspart Injection; Shares Up 3% | MT |
17/04 | Jiangsu Hengrui Medicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
ETFs positioned on Jiangsu Hengrui Medicine Co., Ltd.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
4.18% | 2 M€ | -15.79% | - | |
3.73% | 2 M€ | -14.14% | ||
1.74% | 1 M€ | -9.86% | - | |
1.18% | 96 M€ | -0.43% | ||
0.51% | 35 M€ | -5.85% | - | |
0.27% | 4 M€ | -11.56% | ||
0.15% | 11 M€ | +2.07% | ||
0.07% | 1 M€ | +3.49% | - | |
0.07% | 3 M€ | -.--% | - | |
0.03% | 441 M€ | +5.00% | - | |
0.03% | 2,808 M€ | +6.09% | - | |
0.03% | 149 M€ | +3.21% | - | |
0.03% | 117 M€ | +0.50% | - | |
0.03% | 4 M€ | -4.41% | - | |
0.01% | 31 M€ | +4.15% | - | |
0.00% | 7 M€ | +2.17% | - | |
0.00% | 34 M€ | +1.85% | - | |
0.00% | 389 M€ | +6.58% | - | |
0.00% | 34 M€ | +6.75% | - | |
0.00% | 147 M€ | +4.73% | - | |
0.00% | 39 M€ | +4.26% | - | |
0.00% | 302 M€ | +3.73% | - |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.06% | 40.56B | |
+33.47% | 664B | |
+29.29% | 567B | |
-7.18% | 354B | |
+19.20% | 330B | |
+4.59% | 286B | |
+13.79% | 234B | |
+4.93% | 199B | |
-9.78% | 196B | |
-4.68% | 148B |
- Stock Market
- Equities
- 600276 Stock
- Funds and ETFs Jiangsu Hengrui Medicine Co., Ltd.